Page last updated: 2024-10-24

chlordiazepoxide and Sjogren's Syndrome

chlordiazepoxide has been researched along with Sjogren's Syndrome in 1 studies

Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakai, H1
Fukami, Y1
Ibe, M1
Hashimoto, Y1
Iizuka, H1

Other Studies

1 other study available for chlordiazepoxide and Sjogren's Syndrome

ArticleYear
A case of a fixed drug eruption presenting with a butterfly rash-like exanthem in a patient with Sjögren's syndrome.
    International journal of dermatology, 2005, Volume: 44, Issue:3

    Topics: Chlordiazepoxide; Drug Eruptions; Exanthema; Female; Humans; Middle Aged; Sjogren's Syndrome

2005